{"created":"2023-05-15T14:54:20.372730+00:00","id":73845,"links":{},"metadata":{"_buckets":{"deposit":"117e7da4-5d14-411f-b71d-caca29a4ea5a"},"_deposit":{"created_by":1,"id":"73845","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"73845"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00073845","sets":["1"]},"author_link":["804370","804369","804366","804371","804367","804368"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-08","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"4","bibliographicPageEnd":"1451","bibliographicPageStart":"1434","bibliographicVolumeNumber":"26","bibliographic_titles":[{"bibliographic_title":"Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Cardiac denervation is associated with progressive left ventricular (LV) dysfunction, ventricular arrhythmias, and sudden cardiac death (SCD) in heart failure (HF). In this regard, it is important to evaluate cardiac-specific sympathetic nervous system (SNS) function. The radiotracer Iodine-123 meta-iodobenzylguanidine (123I-mIBG) can noninvasively evaluate pre-synaptic SNS function. Recent multicenter trials have shown 123I-mIBG to have strong predictive value for fatal arrhythmias and cardiac death in HF. 123I-mIBG was initially developed in the USA in the 1970s. In 1992, the Japanese Ministry of Health and Labour approved 123I-mIBG for the assessment of cardiac function. Following approval, the Japanese nuclear cardiology community developed 123I-mIBG imaging services in various medical centers. Japanese groups have been trying to establish the clinical utility of 123I-mIBG and standardize parameters for data acquisition and image analysis. The US Food and Drug Administration (FDA) has approved clinical use of 123I-mIBG for cardiac and non-cardiac imaging. However, clinical use of 123I-mIBG in the US has been very limited. The number of 123I-mIBG studies in Japan has also been limited. There are similarities and differences between the two countries. To establish the clinical utility of 123I-mIBG in both countries, it is important to characterize the situations of 123I-mIBG in each.","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Springer"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"30178272","subitem_relation_type_select":"PMID"}}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s12350-018-1394-5","subitem_relation_type_select":"DOI"}}]},"item_8_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://link.springer.com/article/10.1007/s12350-018-1394-5","subitem_relation_type_select":"URI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1071-3581","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"I.Travin, Mark"}],"nameIdentifiers":[{"nameIdentifier":"804366","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Matsunari, Ichiro"}],"nameIdentifiers":[{"nameIdentifier":"804367","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"S. Thomas, Gregory"}],"nameIdentifiers":[{"nameIdentifier":"804368","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nakajima, Kenichi"}],"nameIdentifiers":[{"nameIdentifier":"804369","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yoshinaga, Keiichiro"}],"nameIdentifiers":[{"nameIdentifier":"804370","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yoshinaga, Keiichiro","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"804371","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":" How Do We Establish Cardiac Sympathetic Nervous System Imaging with 123I-mIBG in Clinical Practice? Perspectives and Lessons from Japan and the US","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":" How Do We Establish Cardiac Sympathetic Nervous System Imaging with 123I-mIBG in Clinical Practice? Perspectives and Lessons from Japan and the US"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-09-07"},"publish_date":"2018-09-07","publish_status":"0","recid":"73845","relation_version_is_last":true,"title":[" How Do We Establish Cardiac Sympathetic Nervous System Imaging with 123I-mIBG in Clinical Practice? Perspectives and Lessons from Japan and the US"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:41:33.330357+00:00"}